AP1891A - HIV immunogenic compositions and methods. - Google Patents

HIV immunogenic compositions and methods.

Info

Publication number: AP1891A
Authority: AP; ARIPO
Prior art keywords: mammal; immunogenic compositions; hiv; iss; adjuvant
Prior art date: 1999-05-06

Application number

APAP/P/2001/002300A

Other languages

English (en)

Other versions

AP2001002300A0 (en

Inventor

Ronald B Moss

Original Assignee

The Immune Response Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-06

Filing date

2000-05-05

Publication date

2008-09-23

2000-05-05 Application filed by The Immune Response Corp filed Critical The Immune Response Corp

2001-12-31 Publication of AP2001002300A0 publication Critical patent/AP2001002300A0/xx

2008-09-23 Application granted granted Critical

2008-09-23 Publication of AP1891A publication Critical patent/AP1891A/en

Links

230000002163 immunogen Effects 0.000 title abstract 7
239000000203 mixture Substances 0.000 title abstract 7
238000000034 method Methods 0.000 title abstract 4
241000725303 Human immunodeficiency virus Species 0.000 abstract 8
239000000427 antigen Substances 0.000 abstract 7
102000036639 antigens Human genes 0.000 abstract 7
108091007433 antigens Proteins 0.000 abstract 7
241000124008 Mammalia Species 0.000 abstract 6
239000002671 adjuvant Substances 0.000 abstract 4
230000003308 immunostimulating effect Effects 0.000 abstract 4
102000039446 nucleic acids Human genes 0.000 abstract 4
108020004707 nucleic acids Proteins 0.000 abstract 4
150000007523 nucleic acids Chemical class 0.000 abstract 4
230000002708 enhancing effect Effects 0.000 abstract 2
101710205625 Capsid protein p24 Proteins 0.000 abstract 1
102100027723 Endogenous retrovirus group K member 6 Rec protein Human genes 0.000 abstract 1
101710091045 Envelope protein Proteins 0.000 abstract 1
101710177166 Phosphoprotein Proteins 0.000 abstract 1
101710188315 Protein X Proteins 0.000 abstract 1
101710149279 Small delta antigen Proteins 0.000 abstract 1
102100022563 Tubulin polymerization-promoting protein Human genes 0.000 abstract 1
230000003053 immunization Effects 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

APAP/P/2001/002300A 1999-05-06 2000-05-05 HIV immunogenic compositions and methods. AP1891A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US13276299P	1999-05-06	1999-05-06
US15066799P	1999-08-25	1999-08-25
PCT/US2000/012495 WO2000067787A2 (en)	1999-05-06	2000-05-05	Hiv immunogenic compositions and methods

Publications (2)

Publication Number	Publication Date
AP2001002300A0 AP2001002300A0 (en)	2001-12-31
AP1891A true AP1891A (en)	2008-09-23

Family

ID=26830710

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
APAP/P/2001/002300A AP1891A (en)	1999-05-06	2000-05-05	HIV immunogenic compositions and methods.

Country Status (8)

Country	Link
EP (1)	EP1176978A2 (es)
AP (1)	AP1891A (es)
AU (1)	AU4992900A (es)
BR (1)	BR0010323A (es)
CA (1)	CA2372960C (es)
CR (1)	CR6491A (es)
OA (1)	OA11937A (es)
WO (1)	WO2000067787A2 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6207646B1 (en)	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
CA2328894A1 (en)	1998-05-22	1999-12-02	Loeb Health Research Institute At The Ottawa Hospital	Methods and products for inducing mucosal immunity
WO2000039304A2 (en)	1998-12-31	2000-07-06	Chiron Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2221600A (en)	1998-12-31	2000-07-31	Chiron Corporation	Improved expression of hiv polypeptides and production of virus-like particles
EP2204186B1 (en)	1999-02-17	2016-04-06	CSL Limited	Immunogenic complexes and methods relating thereto
US6977245B2 (en)	1999-04-12	2005-12-20	The United States Of America As Represented By The Department Of Health And Human Services	Oligodeoxynucleotide and its use to induce an immune response
ES2250151T3 (es) *	1999-06-29	2006-04-16	Glaxosmithkline Biologicals S.A.	Uso de cpg como adyuvante de vacuna contra vih.
WO2001051500A1 (en)	2000-01-14	2001-07-19	The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Oligodeoxynucleotide and its use to induce an immune response
DE60142410D1 (de)	2000-12-27	2010-07-29	Dynavax Tech Corp	Immunomodulatorische polynukleotide und verfahren zur deren verwendung
WO2002058726A1 (en) *	2001-01-26	2002-08-01	The Immune Response Corporation	Method for treating an hiv-infected individual by combining immunization with structured interruption of anti-retroviral treatment
US20030199466A1 (en)	2001-06-21	2003-10-23	Fearon Karen L.	Chimeric immunomodulatory compounds and methods of using the same - ll
EP2412242A3 (en)	2001-07-05	2012-06-13	Novartis Vaccines and Diagnostics, Inc.	Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
US7354909B2 (en)	2001-08-14	2008-04-08	The United States Of America As Represented By Secretary Of The Department Of Health And Human Services	Method for rapid generation of mature dendritic cells
DK1446162T3 (da)	2001-08-17	2008-12-08	Coley Pharm Gmbh	Kombinationsmotiv-immunstimulatoriske oligonukleotider med forbedret aktivitet
US20030170614A1 (en)	2001-08-31	2003-09-11	Megede Jan Zur	Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
AR045702A1 (es)	2001-10-03	2005-11-09	Chiron Corp	Composiciones de adyuvantes.
US7615227B2 (en)	2001-12-20	2009-11-10	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Use of CpG oligodeoxynucleotides to induce angiogenesis
CA2388049A1 (en)	2002-05-30	2003-11-30	Immunotech S.A.	Immunostimulatory oligonucleotides and uses thereof
US7807803B2 (en)	2002-07-03	2010-10-05	Coley Pharmaceutical Group, Inc.	Nucleic acid compositions for stimulating immune responses
AU2003247880B2 (en) *	2002-07-03	2010-09-02	Coley Pharmaceutical Group, Inc.	Nucleic acid compositions for stimulating immune responses
US20040053880A1 (en)	2002-07-03	2004-03-18	Coley Pharmaceutical Group, Inc.	Nucleic acid compositions for stimulating immune responses
US7605138B2 (en)	2002-07-03	2009-10-20	Coley Pharmaceutical Group, Inc.	Nucleic acid compositions for stimulating immune responses
US7569553B2 (en)	2002-07-03	2009-08-04	Coley Pharmaceutical Group, Inc.	Nucleic acid compositions for stimulating immune responses
US7576066B2 (en)	2002-07-03	2009-08-18	Coley Pharmaceutical Group, Inc.	Nucleic acid compositions for stimulating immune responses
KR20050089799A (ko)	2002-10-29	2005-09-08	콜리 파마슈티칼 그룹, 리미티드	Ｃ형 간염 바이러스 감염의 치료에 있어 ＣｐＧ올리고뉴클레오티드의 용도
CA2502015A1 (en)	2002-12-11	2004-06-24	Coley Pharmaceutical Group, Inc.	5' cpg nucleic acids and methods of use
US8158768B2 (en)	2002-12-23	2012-04-17	Dynavax Technologies Corporation	Immunostimulatory sequence oligonucleotides and methods of using the same
DE60329223D1 (de)	2002-12-23	2009-10-22	Dynavax Tech Corp	Oligonukleotide mit einer immunsystemstimulierenden sequenz und verfahren zu deren anwendung
US20050196411A1 (en) *	2003-08-28	2005-09-08	Moss Ronald B.	Immunogenic HIV compositions and related methods
MY159370A (en)	2004-10-20	2016-12-30	Coley Pharm Group Inc	Semi-soft-class immunostimulatory oligonucleotides
CN101517082B (zh)	2006-09-27	2014-01-22	科勒制药有限责任公司	具有增强的免疫刺激活性的含疏水性T类似物的CpG寡聚核苷酸类似物
WO2010051820A1 (en) *	2008-11-10	2010-05-14	Aarhus Universitet	Multiplexed cytokine vaccination
ES2702318T3 (es)	2011-07-06	2019-02-28	Glaxosmithkline Biologicals Sa	Emulsiones catiónicas de aceite en agua
CN103781470A (zh)	2011-07-06	2014-05-07	诺华股份有限公司	包含核酸的水包油乳液

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998055495A2 (en) *	1997-06-06	1998-12-10	Dynavax Technologies Corporation	Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1005368B1 (en) *	1997-03-10	2009-09-02	Ottawa Hospital Research Institute	Use of nucleic acids containing unmethylated CpG dinucleotide in combination with alum as adjuvants

2000
- 2000-05-05 WO PCT/US2000/012495 patent/WO2000067787A2/en not_active Ceased
- 2000-05-05 EP EP00932163A patent/EP1176978A2/en not_active Withdrawn
- 2000-05-05 AP APAP/P/2001/002300A patent/AP1891A/en active
- 2000-05-05 AU AU49929/00A patent/AU4992900A/en not_active Abandoned
- 2000-05-05 BR BR0010323-3A patent/BR0010323A/pt not_active IP Right Cessation
- 2000-05-05 CA CA002372960A patent/CA2372960C/en not_active Expired - Fee Related
- 2000-05-05 OA OA1200100291A patent/OA11937A/en unknown
2001
- 2001-10-25 CR CR6491A patent/CR6491A/es not_active Application Discontinuation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998055495A2 (en) *	1997-06-06	1998-12-10	Dynavax Technologies Corporation	Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Vaccine, GB, Butterworth Scientific, Guildford, Vol. 16, No. 7, 1 *
Vaccine, Vol. 18, No. 11-12, 01/2000 *

Also Published As

Publication number	Publication date
OA11937A (en)	2006-04-12
BR0010323A (pt)	2002-01-08
AU4992900A (en)	2000-11-21
WO2000067787A2 (en)	2000-11-16
CR6491A (es)	2005-05-31
CA2372960A1 (en)	2000-11-16
AP2001002300A0 (en)	2001-12-31
WO2000067787A3 (en)	2001-04-26
EP1176978A2 (en)	2002-02-06
CA2372960C (en)	2006-03-28

Publication	Publication Date	Title
AP1891A (en)	2008-09-23	HIV immunogenic compositions and methods.
WO2005013918A3 (en)	2005-12-29	Compositions, methods and kits relating to poxvirus subunit vaccines
WO2000062800A3 (en)	2001-01-11	Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
MXPA01011047A (es)	2003-10-14	Secuencias genomicas de neisseria y metodos para su uso.
MY129263A (en)	2007-03-30	Vaccine composition
PL366826A1 (en)	2005-02-07	Reducing the immunogenicity of fusion proteins
TW200621806A (en)	2006-07-01	Vaccine
WO2001053463A3 (en)	2002-02-14	COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF HER-2/neu ASSOCIATED MALIGNANCIES
MXPA01003557A (es)	2004-04-05	Secuencias genomicas de neisseria y metodos para su uso.
IL155283A0 (en)	2003-11-23	Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol
AU2001262345A1 (en)	2001-12-17	Antigenic composition comprising a polycationic peptide and inosine and cytosine
BR0107972A (pt)	2002-11-05	Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
WO2004007679A3 (en)	2004-10-14	Dendritic cell pontentiation
MXPA04001224A (es)	2004-05-27	Agentes para incrementar la respuesta inmune.
ATE315404T1 (de)	2006-02-15	Influenzavirus-impfstoffzusammensetzung
NZ525752A (en)	2004-10-29	HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
NZ333500A (en)	2000-09-29	Vaccines comprising HIV gp120 envelope polypeptides from vaccinees vaccinated with an earlier HIV gp120 vaccine and subsequently infected with HIV
WO2003082183A3 (en)	2004-01-15	Protein-based streptococcus pneumoniae vaccines
WO2002036790A3 (en)	2003-01-23	Influenza virus vector for infection of dendritic cells
BR9712556A (pt)	1999-10-19	Plasmìdeo, composição farmacêutica, e, processo de imunizar um indivìduo contra um antìgeno
WO2005021726A3 (en)	2008-01-17	Immunogenic hiv compositions and related methods
TW200502245A (en)	2005-01-16	Vaccine
AU6078399A (en)	2000-04-17	Ligand presenting assembly (lpa), method of preparation and uses thereof
MXPA02003328A (es)	2004-09-10	Vacuna.
MY127452A (en)	2006-12-29	Vaccines.